Variants of human prolactin and human placeatal lactogen

Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4353201, 435325, 435 694, 530399, 536 2351, C07K 14575, C12N 1516

Patent

active

059553464

ABSTRACT:
The invention provides methods for the systematic analysis of the structure and function of polypeptides by identifying active domains which influence the activity of the polypeptide with a target substance. Such active domains are determined by substituting selected amino acid segments of the polypeptide with an analogous polypeptide segment from an analog to the polypeptide. The analog has a different activity with the target substance as compared to the parent polypeptide. The activities of the segment-substituted polypeptides are compared to the same activity for the parent polypeptide for the target. A comparison of such activities provides an indication of the location of the active domain in the parent polypeptide. The invention also provides methods for identifying the active amino acid residues within the active domain of the parent polypeptide. The method comprises substituting a scanning amino acid for one of the amino acid residues within the active domain of the parent polypeptide and assaying the residue-substituted polypeptide so formed with a target substance. The invention further provides polypeptide variants comprising segment-substituted and residue-substituted growth hormones, prolactins and placental lactogens.

REFERENCES:
patent: 4446235 (1984-05-01), Seeburg
patent: 4665160 (1987-05-01), Seeburg
patent: 4670393 (1987-06-01), Seeburg
patent: 4699897 (1987-10-01), Jones et al.
patent: 4732973 (1988-03-01), Borr et al.
patent: 4871835 (1989-10-01), Aviv et al.
patent: 4888286 (1989-12-01), Crea
patent: 5085862 (1992-02-01), Klein et al.
patent: 5204244 (1993-04-01), Fell et al.
patent: 5350836 (1994-09-01), Kopchick et al.
Nicoll et al.,"Structural Features Of Prolactins and Growth Hormones That Can Be Related to Their Biological Properties", Endocrine Reviews 7:169-203 (1986).
Abdel-Maeguid, S. S. et al., "Three-dimensional structure of a genetically engineered variant of porcine growth hormone", 84 Proc. Natl. Acad. Sci. USA 6434-6437 (1987).
Bajt et al., Characterization of a Gain of Function Mutation of Integrin .alpha.II.beta.3 (Platelet Glycoprotein IIb-IIIa), 267 J. Biol. Chem. 22211-22216 (1992).
Barlow, D. J. et al., "Continuous and discontinuous protein antigenic determinants", 322 Nature 747-748 (1986).
Bennett et al., "High Resolution Analysis of Functional Determinants of Human Tissue-type Plasminogen Activator", 266 J. Biol. Chem. 5191-5201 (1991).
Berendt et al., "The Binding Site of ICAM-1 for Plasmodium falciparum-Infected Erythrocytes Overlaps, but is Distinct LFA-1 Binding Site", 68 Cell 71-81 (1992).
Berlot et al., "Identification of Effector-Activating Residues of G s.alpha.", 68 Cell 911-922 (1992).
Bettler et al., "Immunoglobulin E-binding Site in Fc Receptor (FcRII/CD23) Identified by Homolog-scanning Mutagenesis", 267 J. Biol. Chem. 185-191 (1992).
Boutin, J. M. et al., "Cloning and Expression of the Rat Prolactin Receptor, a Member of the Growth Hormone/ Prolactin Receptor Gene Family", 53 Cell 69-77 (1988).
Burstein et al., "Immunoreactivity and receptor binding of mixed recombinants of human growth hormone and chorionic somatomammotropin", 75 Proc. Natl. Acad. Sci. USA 5391-5394 (1978).
Camble, R. et al., "Properties of Interferon-.alpha.2 Analogues Produced from Synthetic Genes in Peptides: Structure and Function", Proceedings of the Ninth American Peptide Symposium 375-384 (Deber et al. eds. 1985).
Chang, C. N. et al., "High-level secretion of human growth hormone by Escherichia coli", 55 Gene 189-196 (1987).
Clayton et al., "Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding", 355 Nature 363-366 (1988).
Cunningham, B., "Improvement in the alkaline stability of subtilisin using an efficient random mutagenesis and screening procedure", 108 Chemical Abstracts 11 (1988).
Cunningham, B. et al., "Receptor and Antibody Epitopes in Human Growth Hormone Identified by Homolog-Scanning Mutagenesis", 243 Science 1330-1336 (1989).
Cunningham, B. et al., "High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis", 244 Science 1081-1085 (1989).
Ge et al., "Functional Domains of Bacillus thuringiensis Insecticidal Crystal Proteins", 266 J. Biol. Chem. 17954-17958 (1991).
Geysen et al., 81 P.N.A.S., USA 3998-4002 (1984).
Goeddel et al., "Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone", 281 Nature 544-548 (1979).
Gray et al., "Periplasmic production of correctly processed human growth in Escherichia coli: natural and bacterial signal sequences are interchangeable", 39 Gene 247-254 (1985).
Hotta et al., 149 Biochem. and Biophys. Res. Comm. 531-537 (1987).
Huang et al., 233 FEBS Letters 294-298 (1987).
Jones, P. T. et al., "Replacing the complementarity-determining regions in a human antibody with those from a mouse", 321 Nature 522-525 (1986).
Kobilka, B. et al., "Chemeric .alpha.2-,.beta.2-Adrenergic Receptors: Delineation of Domains Involved in Effector Coupling and Ligand Binding Specificity", 240 Science 1310-1316 (1988).
Kostyo, J. L. et al., "Biological characterization of purified native 20-kDa human growth hormone", 925 Biochemica et Biophysica Acta 314 (1987).
Krivi, G. G. et al., "Immunohistochemical Expression of Insulin-like growth factor I during Skeletal Muscle Regeneration in Normal . . . ", Abstract I-18, Int'l. Symp. on Growth Hormone; Basic and Clin. Aspects, Final Program, sponsored by Serono Symposia, USA (Jun. 14-18, 1987).
Laskowski, M. et al., "Positive Darwinian Selection in Evolution of Protein Inhibitors of Serine Proteinases", 52 Cold Spring Harbor Symp. Quant. Biol. 545 (1987).
Leung, D. W. et al., "Growth hormone receptor and serum binding protein: purification, cloning and expression", 330 Nature 537-543 (1987).
Lewis, U. J. et al., "A Naturally Occurring Structural Variant of Human Growth Hormone", 253 J. Biol. Chem. 2679-2687 (1978).
Lewis, U. J., "Variants of Growth Hormone and Prolactin and Their Posttranslational Modifications", 46 Ann. Rev. Physiol. 33-42 (1984).
Li, C. H., "Human growth hormone: 1974-1981", 46 Mol. Cell. Biochem. 31-41 (1982).
Marseigne et al., 31 J. Med. Chem. 966-970 (1988).
Mills, J. B. et al., "Fragments of Human Growth Hormone Produced by Digestion with Thrombin: Chemistry and Biological Properties", 107 Endocrinology 391-399 (1980).
Nakashima et al., "Alanine-scanning Mutagenesis of the Epidermal Growth Factor-like Domains of Human Thrombomodulin Identifies Critical Residues for Its Cofactor Activity", 268 J. Biol. Chem. 2888-2892 (1993).
Russell et al., "Recombinant Hormones from Fragments of Human Growth Hormone and Human Placental Lactogen", 256 J. Biol. Chem. 296-300 (1981).
Seeberg, P. H., "The Human Growth Hormone Gene Family: Nucleotide Sequences Show Recent Divergence and Predict a New Polypeptide Hormone", 1 DNA 239-249 (1982).
Sourouton, M. C. et al., "Localization of Highly Immunogenic Region on the Acetylcholine Receptor Alpha-Subunit", 135 Biochem. Biophys. Res. Commun. 82-89 (1986).
Tokunaga, T. et al., "Synthesis and expression of a human growth hormone (somatotropin) gene mutated to change cysteine-165 to alanine", 153 Eur. J. Biochem. 445-449 (1985).
Venuti et al., "The Impact of Biotechnology on Drug Discovery", Ann. Reports in Medicinal Chem. 289-298 (Vinick ed. 1989).
Wells, J., "Systematic Mutational Analysis of Protein-Protein Interfaces", 202 Methods in Enzymology 390-411 (1991).
Werther et al., "Localization and Characterization of Insulin Receptors in Rat Brain and Pituitary Gland Using In-Vitro Autoradiography and Computerized Densitometry", 121 Endocrinol. 1562-1570 (1987).
Wertman et al., "Systematic Mutational Analysis of the Yeast ACT1 Gene", 132 Genetics 337-350 (1992).
Wharton, R. P. et al., "Substituting an .alpha.-Helix Switches the Sequence-Specific DNA Interactions of a Repressor", 38 Cell 361-369 (1984).
Wharton, R. P. et al., "Changing the binding specificity of a repressor by redesigning an .alpha.-helix", 316 Nature 601-605 (1985).
Wharton, R. P. et al., 318 Nature 316-369 (1985).
Wu and Wallace, "The Ligation Amplificatio

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Variants of human prolactin and human placeatal lactogen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Variants of human prolactin and human placeatal lactogen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Variants of human prolactin and human placeatal lactogen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-79608

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.